Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The complexity of software architecture and diverse user interactions presents challenges to ...
2d
Pioneering Reliability and Precision: The Rise of Top Environmental Testing Equipment Manufacturers
XIAN HIGH-TECH AREA, SHAANXI, CHINA, January 19, 2026 /EINPresswire.com/ -- With increasing demands for product ...
Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...
Large-scale infrastructure projects, interconnection schemes, and renewable energy developments continue to shape the region’s power landscape. In such projects, even small deviations in CT or PT ...
SEngine Precision Medicine, the precision oncology innovator matching patients to medicines based on their own tumor samples, announces the publication of a new case report showing a patient’s ...
Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results